Toronto Dominion Bank’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$117M Sell
538,014
-542,834
-50% -$120M 0.17% 110
2025
Q4
$247M Buy
1,080,848
+212,218
+24% +$48.3M 0.36% 51
2025
Q3
$201M Buy
868,630
+12,393
+1% +$2.52M 0.31% 57
2025
Q2
$159M Buy
856,237
+203,134
+31% +$37.8M 0.26% 73
2025
Q1
$137M Sell
653,103
-114,489
-15% -$22.3M 0.27% 68
2024
Q4
$136M Buy
767,592
+69,715
+10% +$12.8M 0.22% 66
2024
Q3
$138M Sell
697,877
-243,474
-26% -$45.4M 0.24% 60
2024
Q2
$161M Sell
941,351
-136,985
-13% -$22.7M 0.26% 54
2024
Q1
$196M Buy
1,078,336
+22,404
+2% +$3.86M 0.31% 46
2023
Q4
$164M Buy
1,055,932
+17,413
+2% +$2.54M 0.24% 66
2023
Q3
$155M Sell
1,038,519
-33,293
-3% -$4.89M 0.26% 69
2023
Q2
$144M Sell
1,071,812
-1,683
-0.2% -$247K 0.21% 86
2023
Q1
$171M Buy
1,073,495
+70,240
+7% +$10.7M 0.28% 64
2022
Q4
$162M Buy
1,003,255
+168,330
+20% +$25.8M 0.24% 71
2022
Q3
$112M Sell
834,925
-141,332
-14% -$20.3M 0.2% 76
2022
Q2
$149M Sell
976,257
-141,651
-13% -$21.6M 0.28% 57
2022
Q1
$181M Buy
1,117,908
+8,846
+0.8% +$1.28M 0.27% 58
2021
Q4
$150M Sell
1,109,062
-157,172
-12% -$18.6M 0.2% 76
2021
Q3
$137M Buy
1,266,234
+397,222
+46% +$45.4M 0.21% 72
2021
Q2
$97.9M Sell
869,012
-87,228
-9% -$9.82M 0.15% 95
2021
Q1
$103M Sell
956,240
-245,209
-20% -$26.2M 0.18% 84
2020
Q4
$129M Buy
1,201,449
+105,376
+10% +$10.1M 0.24% 73
2020
Q3
$96M Sell
1,096,073
-151,971
-12% -$14.3M 0.24% 74
2020
Q2
$123M Buy
1,248,044
+80,955
+7% +$7.13M 0.31% 55
2020
Q1
$88.9M Sell
1,167,089
-283,941
-20% -$24.2M 0.27% 71
2019
Q4
$128M Buy
1,451,030
+287,569
+25% +$23.9M 0.22% 81
2019
Q3
$88.1M Sell
1,163,461
-1,086,003
-48% -$74.5M 0.19% 88
2019
Q2
$81.8M Buy
2,249,464
+1,144,894
+104% +$90M 0.17% 89
2019
Q1
$89M Buy
1,104,570
+160,834
+17% +$13.2M 0.14% 88
2018
Q4
$87M Sell
943,736
-89,947
-9% -$7.91M 0.15% 72
2018
Q3
$97.7M Buy
1,033,683
+23,963
+2% +$2.27M 0.18% 72
2018
Q2
$93.5M Buy
1,009,720
+98,538
+11% +$9.62M 0.19% 73
2018
Q1
$86.2M Buy
911,182
+177,240
+24% +$19.5M 0.19% 59
2017
Q4
$71M Buy
733,942
+81,128
+12% +$7.65M 0.21% 67
2017
Q3
$58M Buy
652,814
+62,877
+11% +$4.79M 0.19% 75
2017
Q2
$42.8M Buy
589,937
+85,876
+17% +$5.77M 0.14% 104
2017
Q1
$32.9M Buy
504,061
+173,983
+53% +$10.9M 0.09% 116
2016
Q4
$20.7M Buy
330,078
+233,006
+240% +$14.2M 0.06% 132
2016
Q3
$6.13M Buy
97,072
+38,040
+64% +$2.46M 0.02% 191
2016
Q2
$3.67M Sell
59,032
-4,790
-8% -$292K 0.02% 170
2016
Q1
$3.63M Sell
63,822
-36,869
-37% -$2.05M 0.02% 148
2015
Q4
$5.98M Sell
100,691
-15,158
-13% -$873K 0.04% 136
2015
Q3
$6.31M Buy
115,849
+26,027
+29% +$1.69M 0.04% 140
2015
Q2
$6.03M Buy
89,822
+6,945
+8% +$453K 0.03% 172
2015
Q1
$4.85M Sell
82,877
-13,493
-14% -$815K 0.02% 184
2014
Q4
$6.3M Buy
96,370
+35,693
+59% +$2.25M 0.02% 172
2014
Q3
$3.5M Buy
60,677
+6
+0% +$333 0.01% 207
2014
Q2
$3.42M Buy
60,671
+5,308
+10% +$278K 0.01% 224
2014
Q1
$2.9M Sell
55,363
-484
-0.9% -$24.5K 0.01% 221
2013
Q4
$2.95M Buy
55,847
+28,472
+104% +$1.4M 0.01% 213
2013
Q3
$1.22M Sell
27,375
-2,490
-8% -$110K ﹤0.01% 282
2013
Q2
$1.24M Buy
+29,865
New +$1.31M ﹤0.01% 279

Other funds holding ABBV

Toronto Dominion Bank's ABBV Position: Q1 2026 in Review

Toronto Dominion Bank reduced its AbbVie (ABBV) stake by 50% in Q1 2026, selling an estimated $120M and leaving 538,014 shares worth $117M. The position accounts for 0.17% of the portfolio, ranked #110.

Toronto Dominion Bank first reported a position in ABBV in Q2 2013 and has held it in 52 quarters since. The position peaked at $247M in Q4 2025. 4,077 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.

  • Toronto Dominion Bank held 538,014 shares of AbbVie worth $117M as of Q1 2026.
  • Toronto Dominion Bank sold 542,834 AbbVie shares in Q1 2026, an estimated $120M.
  • AbbVie made up 0.17% of Toronto Dominion Bank's portfolio in Q1 2026, its #110 holding.
  • Toronto Dominion Bank first reported a position in AbbVie in Q2 2013 and has held it in 52 quarters since.
  • Toronto Dominion Bank's AbbVie position peaked at $247M in Q4 2025.
  • 4,077 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.

Based on Toronto Dominion Bank's 13F filing for Q1 2026, filed 15 May 2026.